We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Another Generics Maker Gets FDA Warning for Skipping GDUFA Fees
Another Generics Maker Gets FDA Warning for Skipping GDUFA Fees
The FDA continues to crack down on generic drugmakers that owe GDUFA fees, hitting Indian drugmaker Vista Pharmaceuticals with a warning letter for failing to pay fees for the last three fiscal years.